Expertise in Projects for Health/Life Sciences


We work with specific techniques that allow for greater accuracy of information.

Some methodologies and techniques on different dimensions of the relationship with different stakeholders, to identify more realistic opportunities and forecasts.

DIARY
STUDY


  Prescriptive habit, decision-making process on available treatments through cases of real patients.

  It limits generalizations and rationalizations about daily conduct.

  It allows evaluating changes in the course of treatment, and identifying characteristics of patients capable of modifying the course of treatment.

Patient Journey and
Patient Experience


  Knowledge of all stages and possibilities of the patient's treatment journey allows us to identify opportunities to generate value for the relationship with those involved through the launch or adaptation of products and services.

  It can be built by combining the views of doctors and patients.

  It can be carried out with the aim of generating journalistic agenda about the organization's relationship/contribution with knowledge and generation of dialogue about a specific disease/condition.

  • It is estimated that there are currently about 7,000 to 8,000 rare diseases in the world, which affect between 6% and 8% of the world population, 13 million of which are in Brazil alone.

  • The Ministry of Health considers a rare disease to be one that affects up to 65 people per 100,000 individuals or 1.3 per 2,000 people. 80% of rare diseases are genetic in origin.

  • The treatment involves, in most cases, clinical protocols of high cost and complexity. The treatment is not always easily accessible. The most frequent way out to guarantee access to medicines and specialized care continues to be through legal proceedings.

  • The main challenge is to ensure better care for millions of people who suffer from these diseases that are difficult to diagnose and treat.

  • Some alternatives are already being put into practice, such as continuing medical education in medical genetics, developed by CFM in partnership with the Brazilian Society of Medical Genetics (SBGM), presented in August, during the 2nd Forum of the Federal Council of Medicine (CFM ). The objective is to promote scientific updating that enables physicians to make early diagnoses, change the course of disease development and increase the quality of life of patients.

  • Another alternative is to know the journey of patients diagnosed with rare diseases, to know the obstacles, challenges in the diagnostic processes, seeking treatment and improving the quality of life.

  • Lumini Knowledge has already carried out projects with this focus, for various diseases and rare diseases. Empathy and deep listening throughout the process, in addition to practical experience in mapping journeys and value chains, was fundamental to connecting the experiences of patients and caregivers with companies interested in providing solutions and adding value to their relationship with them. The sharing of findings with the teams involved took place through co-creation workshops, which allow for an immersion in the patient's journey, appropriation of knowledge, creation of consistent action plans and differentiated solutions.

BRAND
TRACKING



  It allows evaluating which attributes determine the choice for a treatment, the order of relevance among them, and how treatment options are perceived according to these attributes.

  Allows you to know the opportunities to increase overall satisfaction with a specific treatment.

Anne Koch

Planning and Service